DK1558620T3 - Rutheniumkomplekser med anticancervirkning - Google Patents

Rutheniumkomplekser med anticancervirkning

Info

Publication number
DK1558620T3
DK1558620T3 DK03762788T DK03762788T DK1558620T3 DK 1558620 T3 DK1558620 T3 DK 1558620T3 DK 03762788 T DK03762788 T DK 03762788T DK 03762788 T DK03762788 T DK 03762788T DK 1558620 T3 DK1558620 T3 DK 1558620T3
Authority
DK
Denmark
Prior art keywords
anticancer effect
ruthenium complexes
ruthenium
formula
complexes
Prior art date
Application number
DK03762788T
Other languages
Danish (da)
English (en)
Inventor
Peter John Sadler
Lainez Rafael Fernandez
Abraba Habtemariam
Michael Melchart
Duncan Ian Jodrell
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Application granted granted Critical
Publication of DK1558620T3 publication Critical patent/DK1558620T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03762788T 2002-07-05 2003-07-04 Rutheniumkomplekser med anticancervirkning DK1558620T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0215526.5A GB0215526D0 (en) 2002-07-05 2002-07-05 Anticancer compounds
PCT/GB2003/002879 WO2004005304A1 (en) 2002-07-05 2003-07-04 Ruthenium anticancer complexes

Publications (1)

Publication Number Publication Date
DK1558620T3 true DK1558620T3 (da) 2009-01-05

Family

ID=9939861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03762788T DK1558620T3 (da) 2002-07-05 2003-07-04 Rutheniumkomplekser med anticancervirkning

Country Status (20)

Country Link
US (1) US20060058270A1 (enExample)
EP (1) EP1558620B1 (enExample)
JP (1) JP2005536487A (enExample)
KR (1) KR20050053589A (enExample)
CN (1) CN100362005C (enExample)
AT (1) ATE407937T1 (enExample)
AU (1) AU2003251159B2 (enExample)
BR (1) BR0312470A (enExample)
CA (1) CA2491640A1 (enExample)
DE (1) DE60323529D1 (enExample)
DK (1) DK1558620T3 (enExample)
ES (1) ES2314245T3 (enExample)
GB (1) GB0215526D0 (enExample)
MX (1) MXPA05000314A (enExample)
NO (1) NO20050640L (enExample)
NZ (1) NZ538005A (enExample)
PL (1) PL373049A1 (enExample)
PT (1) PT1558620E (enExample)
WO (1) WO2004005304A1 (enExample)
ZA (1) ZA200500908B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303393T1 (de) * 1999-10-27 2005-09-15 Univ Court The University Of E Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
US7241913B2 (en) 2003-04-30 2007-07-10 The University Court Of The University Of Edinburgh Ruthenium compounds
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
EP2016085B9 (en) * 2006-05-09 2015-12-30 Ecole Polytechnique Fédérale de Lausanne (EPFL) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
DE102009053392A1 (de) * 2009-11-14 2011-06-22 Umicore AG & Co. KG, 63457 Verfahren zur Herstellung von Ru(0) Olefin-Komplexen
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
CN103360428A (zh) * 2012-04-09 2013-10-23 中国科学院化学研究所 抑制蛋白酪氨酸磷酸酶1b活性的含钌配合物及其制备方法和蛋白酪氨酸磷酸酶1b抑制剂
CN102964385B (zh) * 2012-11-30 2015-02-18 广西师范学院 一种有机金属钌化合物及其制备方法和用途
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same
CZ310511B6 (cs) * 2023-09-18 2025-09-10 Univerzita Palackého v Olomouci Koordinační sloučeniny osmia pro použití pro léčbu plicních nádorových onemocnění

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
DE69634639T2 (de) * 1995-12-06 2006-03-02 Japan Science And Technology Agency, Kawaguchi Verfahren zur herstellung optische aktive verbindungen
ATE303393T1 (de) * 1999-10-27 2005-09-15 Univ Court The University Of E Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds

Also Published As

Publication number Publication date
PT1558620E (pt) 2008-12-03
WO2004005304A1 (en) 2004-01-15
EP1558620A1 (en) 2005-08-03
BR0312470A (pt) 2005-04-26
ATE407937T1 (de) 2008-09-15
US20060058270A1 (en) 2006-03-16
CN1665826A (zh) 2005-09-07
DE60323529D1 (de) 2008-10-23
GB0215526D0 (en) 2002-08-14
NO20050640L (no) 2005-03-22
ES2314245T3 (es) 2009-03-16
KR20050053589A (ko) 2005-06-08
AU2003251159B2 (en) 2008-11-06
EP1558620B1 (en) 2008-09-10
NZ538005A (en) 2007-08-31
CA2491640A1 (en) 2004-01-15
ZA200500908B (en) 2006-03-29
JP2005536487A (ja) 2005-12-02
PL373049A1 (en) 2005-08-08
CN100362005C (zh) 2008-01-16
AU2003251159A1 (en) 2004-01-23
MXPA05000314A (es) 2005-09-20

Similar Documents

Publication Publication Date Title
GB0223038D0 (en) Therapeutic compounds
IL164509A0 (en) Furyl compounds
ATE408601T1 (de) Fredericamycin-derivate
MXPA05008438A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6.
NO20042035L (no) Forbedret anvendelse av antitumorforbindelse i kreftterapi
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
DK1558620T3 (da) Rutheniumkomplekser med anticancervirkning
MXPA05012894A (es) Benzofuranos 3-sustituidos como agentes terapeuticos.
WO2003106384A3 (en) Novel boronic chalcone derivatives and uses thereof
TW200630367A (en) Substituted adenines and the uses thereof
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
DE60013486D1 (de) Verbindungen
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
NO20055650L (no) Ruteinum (II)-komplekser for behandling av tumorer
EA200802136A1 (ru) Лечение меланомы
DE60143681D1 (de) Kombinationstherapie gegen Tumoren mit substituierten Acryloyl-Distamycin-Derivaten, Taxanen und/oder Antimetaboliten
ATE336244T1 (de) Metallorganisches antitumormittel
MX2008001548A (es) Compuestos antitumorales.
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
WO2004089300A3 (en) Sapphyrins and uses thereof
TR200401036T1 (tr) Yüksek kan basıncının tedavisi için citalopram.
IL159469A0 (en) Xenogenic oligo-or/and polyribonucleotides as agents for the treatment of malignant tumours